Q48. Consider the following statements about Rotavac :
1. It holds the WHO pre-qualification status
2. ROTAVAC is a part of National Immunization Programme in India
3. It protects against childhood polio caused by rotavirus.
Which of the above statement(s) is are correct?
Q48. Consider the following statements about Rotavac :
1. It holds the WHO pre-qualification status
2. ROTAVAC is a part of National Immunization Programme in India
3. It protects against childhood polio caused by rotavirus.
Which of the above statement(s) is are correct?
The correct option is C (c) Only 1 and 2
Hyderabad-based Bharat Biotech Ltd on Wednesday announced that it had earned the World Health Organization (WHO) pre-qualification tag for its rotavirus vaccine, ROTAVAC.
The WHO pre-qualification paves the way for health and humanitarian organizations such as Unicef, GAVI and Pan-American Health Organization to procure it for public health vaccination programmes across the world.
The move indicates that the WHO has given the vaccine its stamp of approval in safety and efficacy and United Nations procuring agencies may source it.
India had introduced ROTAVAC into its National Immunization Programme during 2016, with 35 million doses delivered till date.
Rotavirus is the most common cause of severe diarrhoea and kills more than 200,000 children every year. While child deaths from rotavirus have more than halved since 2000, almost half of the deaths each year occur in just four countries: India, Pakistan, Nigeria and the Democratic Republic of Congo, according to the WHO.
A national immunization programme (NIP) is the organizational component of Ministries of Health charged with preventing disease, disability, and death from vaccine-preventable diseases in children and adults. A NIP is a government programme that operates within the framework of overall health policy.
The national immunization programme is used interchangeably with the Expanded Programme on Immunization (EPI) that originally focused on preventing vaccine-preventable diseases in children. All countries have a national immunization programme to protect the population against vaccine-preventable diseases.
(c) Only 1 and 2
Hyderabad-based Bharat Biotech Ltd on Wednesday announced that it had earned the World Health Organization (WHO) pre-qualification tag for its rotavirus vaccine, ROTAVAC.
The WHO pre-qualification paves the way for health and humanitarian organizations such as Unicef, GAVI and Pan-American Health Organization to procure it for public health vaccination programmes across the world.
The move indicates that the WHO has given the vaccine its stamp of approval in safety and efficacy and United Nations procuring agencies may source it.
India had introduced ROTAVAC into its National Immunization Programme during 2016, with 35 million doses delivered till date.
Rotavirus is the most common cause of severe diarrhoea and kills more than 200,000 children every year. While child deaths from rotavirus have more than halved since 2000, almost half of the deaths each year occur in just four countries: India, Pakistan, Nigeria and the Democratic Republic of Congo, according to the WHO.
A national immunization programme (NIP) is the organizational component of Ministries of Health charged with preventing disease, disability, and death from vaccine-preventable diseases in children and adults. A NIP is a government programme that operates within the framework of overall health policy.
The national immunization programme is used interchangeably with the Expanded Programme on Immunization (EPI) that originally focused on preventing vaccine-preventable diseases in children. All countries have a national immunization programme to protect the population against vaccine-preventable diseases.
